Emma Rayner

3.1k total citations
51 papers, 1.6k citations indexed

About

Emma Rayner is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Emma Rayner has authored 51 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Infectious Diseases, 14 papers in Epidemiology and 11 papers in Immunology. Recurrent topics in Emma Rayner's work include Tuberculosis Research and Epidemiology (16 papers), Viral Infections and Vectors (15 papers) and Viral Infections and Outbreaks Research (10 papers). Emma Rayner is often cited by papers focused on Tuberculosis Research and Epidemiology (16 papers), Viral Infections and Vectors (15 papers) and Viral Infections and Outbreaks Research (10 papers). Emma Rayner collaborates with scholars based in United Kingdom, Spain and United States. Emma Rayner's co-authors include Stuart Dowall, Roger Hewson, Victoria Graham, Miles W. Carroll, Robert J. Watson, Simon Clark, Ann Williams, Geoff Pearson, Andrew Bosworth and Stephen Findlay‐Wilson and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Virology.

In The Last Decade

Emma Rayner

49 papers receiving 1.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Emma Rayner 1.1k 447 441 346 240 51 1.6k
Patrick W. Hanley 1.4k 1.3× 198 0.4× 495 1.1× 167 0.5× 216 0.9× 61 2.0k
Kasi Russell‐Lodrigue 1.2k 1.1× 343 0.8× 629 1.4× 389 1.1× 261 1.1× 56 1.9k
Moustapha Mbow 716 0.6× 493 1.1× 320 0.7× 594 1.7× 166 0.7× 67 2.1k
Steven B. Kleiboeker 935 0.8× 150 0.3× 555 1.3× 171 0.5× 204 0.8× 58 1.7k
Claude Guiguen 728 0.6× 235 0.5× 654 1.5× 147 0.4× 79 0.3× 88 1.4k
Paloma Rueda 1.1k 1.0× 104 0.2× 506 1.1× 342 1.0× 567 2.4× 58 2.2k
Huot Khun 1.2k 1.1× 1.3k 2.9× 271 0.6× 372 1.1× 300 1.3× 27 2.4k
Taru Meri 991 0.9× 330 0.7× 286 0.6× 553 1.6× 127 0.5× 43 1.9k
Juan E. Ludert 2.0k 1.8× 986 2.2× 401 0.9× 174 0.5× 337 1.4× 89 3.0k
Gustavo Valbuena 787 0.7× 531 1.2× 179 0.4× 244 0.7× 164 0.7× 52 1.6k

Countries citing papers authored by Emma Rayner

Since Specialization
Citations

This map shows the geographic impact of Emma Rayner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Rayner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Rayner more than expected).

Fields of papers citing papers by Emma Rayner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Rayner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Rayner. The network helps show where Emma Rayner may publish in the future.

Co-authorship network of co-authors of Emma Rayner

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Rayner. A scholar is included among the top collaborators of Emma Rayner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Rayner. Emma Rayner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Graham, Victoria, Linda Easterbrook, Emma Rayner, et al.. (2023). Pathogenesis of Rift Valley Fever Virus in a BALB/c Mouse Model Is Affected by Virus Culture Conditions and Sex of the Animals. Viruses. 15(12). 2369–2369. 4 indexed citations
4.
Hunter, Laura, et al.. (2023). Comparative pathology of experimental pulmonary tuberculosis in animal models. Frontiers in Veterinary Science. 10. 1264833–1264833. 10 indexed citations
5.
Gilbride, Ciarán, Stuart Dowall, Susan Morris, et al.. (2023). Adenoviral vectored vaccination protects against Crimean-Congo Haemorrhagic Fever disease in a lethal challenge model. EBioMedicine. 90. 104523–104523. 20 indexed citations
6.
7.
White, Andrew, Laura Sibley, Charlotte Sarfas, et al.. (2021). MTBVAC vaccination protects rhesus macaques against aerosol challenge with M. tuberculosis and induces immune signatures analogous to those observed in clinical studies. npj Vaccines. 6(1). 4–4. 33 indexed citations
8.
Hartley, M. Gill, Isobel H. Norville, Kevin R. Bewley, et al.. (2021). Finafloxacin, a Novel Fluoroquinolone, Reduces the Clinical Signs of Infection and Pathology in a Mouse Model of Q Fever. Frontiers in Microbiology. 12. 760698–760698. 5 indexed citations
9.
Clark, Simon, et al.. (2017). Revaccination of Guinea Pigs With the Live Attenuated Mycobacterium tuberculosis Vaccine MTBVAC Improves BCG's Protection Against Tuberculosis. The Journal of Infectious Diseases. 216(5). 525–533. 33 indexed citations
10.
Dowall, Stuart, Frédéric Jacquot, J. Landon, et al.. (2017). Post-exposure treatment of non-human primates lethally infected with Ebola virus with EBOTAb, a purified ovine IgG product. Scientific Reports. 7(1). 4099–4099. 9 indexed citations
11.
Larrouy‐Maumus, Gerald, Emilie Layre, Simon Clark, et al.. (2017). Protective efficacy of a lipid antigen vaccine in a guinea pig model of tuberculosis. Vaccine. 35(10). 1395–1402. 38 indexed citations
12.
Morton, Penny E., Elena Ortíz-Zapater, Alistair Noble, et al.. (2016). TNFα promotes CAR-dependent migration of leukocytes across epithelial monolayers. Scientific Reports. 6(1). 26321–26321. 17 indexed citations
13.
Dowall, Stuart, Andrew Bosworth, Emma Rayner, et al.. (2016). Post-exposure treatment of Ebola virus disease in guinea pigs using EBOTAb, an ovine antibody-based therapeutic. Scientific Reports. 6(1). 30497–30497. 8 indexed citations
14.
Dowall, Stuart, Victoria Graham, Emma Rayner, et al.. (2016). Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses. PLoS ONE. 11(6). e0156637–e0156637. 58 indexed citations
15.
Tree, Julia A., G.A. Hall, G. R. Pearson, et al.. (2015). Sequence of Pathogenic Events in Cynomolgus Macaques Infected with Aerosolized Monkeypox Virus. Journal of Virology. 89(8). 4335–4344. 27 indexed citations
16.
Bottai, Daria, Wafa Frigui, Simon Clark, et al.. (2015). Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system. Vaccine. 33(23). 2710–2718. 48 indexed citations
17.
Sibley, Laura, Mike Dennis, Charlotte Sarfas, et al.. (2015). Route of delivery to the airway influences the distribution of pulmonary disease but not the outcome of Mycobacterium tuberculosis infection in rhesus macaques. Tuberculosis. 96. 141–149. 18 indexed citations
18.
Dowall, Stuart, Karen R. Buttigieg, Stephen Findlay‐Wilson, et al.. (2015). A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease. Human Vaccines & Immunotherapeutics. 12(2). 519–527. 85 indexed citations
19.
Morton, Penny E., et al.. (2014). TNF alpha promotes coxsackie and adenovirus receptor (CAR) phosphorylation by PKC delta to drive leukocyte transepithelial migration. European Respiratory Journal. 44(Suppl 58). P3853–P3853. 1 indexed citations
20.
Rayner, Emma, G. R. Pearson, G.A. Hall, et al.. (2013). Early Lesions Following Aerosol Infection of Rhesus Macaques (Macaca mulatta) with Mycobacterium tuberculosis Strain H37RV. Journal of Comparative Pathology. 149(4). 475–485. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick W. Hanley Breakdown of academic impact, for papers by Kasi Russell‐Lodrigue Breakdown of academic impact, for papers by Moustapha Mbow Breakdown of academic impact, for papers by Steven B. Kleiboeker Breakdown of academic impact, for papers by Claude Guiguen Breakdown of academic impact, for papers by Paloma Rueda Breakdown of academic impact, for papers by Huot Khun Breakdown of academic impact, for papers by Taru Meri Breakdown of academic impact, for papers by Juan E. Ludert Breakdown of academic impact, for papers by Gustavo Valbuena
Rankless by CCL
2026